1. Home
  2. CYBN vs RELL Comparison

CYBN vs RELL Comparison

Compare CYBN & RELL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYBN
  • RELL
  • Stock Information
  • Founded
  • CYBN 2019
  • RELL 1947
  • Country
  • CYBN Canada
  • RELL United States
  • Employees
  • CYBN N/A
  • RELL N/A
  • Industry
  • CYBN Pharmaceuticals and Biotechnology
  • RELL Electronic Components
  • Sector
  • CYBN Health Care
  • RELL Technology
  • Exchange
  • CYBN Nasdaq
  • RELL Nasdaq
  • Market Cap
  • CYBN 176.5M
  • RELL 163.0M
  • IPO Year
  • CYBN N/A
  • RELL N/A
  • Fundamental
  • Price
  • CYBN $5.94
  • RELL $11.84
  • Analyst Decision
  • CYBN Strong Buy
  • RELL
  • Analyst Count
  • CYBN 3
  • RELL 0
  • Target Price
  • CYBN $85.00
  • RELL N/A
  • AVG Volume (30 Days)
  • CYBN 700.6K
  • RELL 126.7K
  • Earning Date
  • CYBN 11-12-2025
  • RELL 10-08-2025
  • Dividend Yield
  • CYBN N/A
  • RELL 2.08%
  • EPS Growth
  • CYBN N/A
  • RELL N/A
  • EPS
  • CYBN N/A
  • RELL 0.01
  • Revenue
  • CYBN N/A
  • RELL $209,791,000.00
  • Revenue This Year
  • CYBN N/A
  • RELL $3.90
  • Revenue Next Year
  • CYBN N/A
  • RELL $15.83
  • P/E Ratio
  • CYBN N/A
  • RELL $945.53
  • Revenue Growth
  • CYBN N/A
  • RELL 6.17
  • 52 Week Low
  • CYBN $4.81
  • RELL $7.57
  • 52 Week High
  • CYBN $13.88
  • RELL $15.51
  • Technical
  • Relative Strength Index (RSI)
  • CYBN 43.28
  • RELL 69.21
  • Support Level
  • CYBN $5.93
  • RELL $11.08
  • Resistance Level
  • CYBN $6.63
  • RELL $12.49
  • Average True Range (ATR)
  • CYBN 0.32
  • RELL 0.58
  • MACD
  • CYBN 0.02
  • RELL 0.22
  • Stochastic Oscillator
  • CYBN 19.23
  • RELL 55.92

About CYBN Cybin Inc.

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.

About RELL Richardson Electronics Ltd.

Richardson Electronics Ltd provides engineered solutions, power grid, and microwave tubes and related consumables, power conversion, RF and microwave components, high-value flat panel detector solutions, replacement parts, tubes, and service training for diagnostic imaging equipment and customized display solutions. The company's segment includes Power and Microwave Technologies, Green Energy Solutions, Canvys, and Healthcare. The company generates the majority of its revenue from the Power and Microwave Technologies segment, which includes the power grid and microwave tube business and RF, Wireless and Power technologies.

Share on Social Networks: